These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12748469)

  • 1. Expression of cyclooxygenase-2 in cervical, endometrial, and ovarian malignancies.
    Landen CN; Mathur SP; Richardson MS; Creasman WT
    Am J Obstet Gynecol; 2003 May; 188(5):1174-6. PubMed ID: 12748469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
    Kim YB; Kim GE; Pyo HR; Cho NH; Keum KC; Lee CG; Seong J; Suh CO; Park TK
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):822-9. PubMed ID: 15465199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyrimidine nucleoside phosphorylase activity in normal tissues of the uterus and ovary and in benign and malignant lesions of these organs.
    Suzuki M; Usui N; Furugen Y; Mitsuhasi N
    Int J Clin Oncol; 2001 Feb; 6(1):19-24. PubMed ID: 11706522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2 is overexpressed in human cervical cancer.
    Kulkarni S; Rader JS; Zhang F; Liapis H; Koki AT; Masferrer JL; Subbaramaiah K; Dannenberg AJ
    Clin Cancer Res; 2001 Feb; 7(2):429-34. PubMed ID: 11234900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High cyclooxygenase-2 expression in cervical adenocarcinomas.
    Chen YJ; Wang LS; Wang PH; Lai CR; Yen MS; Ng HT; Yuan CC
    Gynecol Oncol; 2003 Mar; 88(3):379-85. PubMed ID: 12648590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages.
    Klimp AH; Hollema H; Kempinga C; van der Zee AG; de Vries EG; Daemen T
    Cancer Res; 2001 Oct; 61(19):7305-9. PubMed ID: 11585770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated cyclooxygenase-2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapy.
    Gaffney DK; Holden J; Davis M; Zempolich K; Murphy KJ; Dodson M
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1213-7. PubMed ID: 11286825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of cyclooxygenase-2 in ovarian carcinoma and its significance].
    Luo WZ; Shen J; Zhang Y; Lang JH
    Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(16):1374-6. PubMed ID: 15637815
    [No Abstract]   [Full Text] [Related]  

  • 9. The expression of cyclooxygenase-1 and -2 in proliferative endometrium and endometrial adenocarcinoma.
    Uotila PJ; Erkkola RU; Klemi PJ
    Ann Med; 2002; 34(6):428-33. PubMed ID: 12523498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase 2 expression in serous tumors of the ovary.
    Singhal PK; Spiegel G; Driscoll D; Odunsi K; Lele S; Rodabaugh KJ
    Int J Gynecol Pathol; 2005 Jan; 24(1):62-6. PubMed ID: 15626918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha-L-fucosidase activity in endometrial, cervical and ovarian cancer.
    Vesce F; Biondi C
    Eur J Gynaecol Oncol; 1983; 4(2):135-8. PubMed ID: 6873092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 and c-erbB-2 expression in uterine cervical neoplasm assessed using tissue microarrays.
    Kim JY; Lim SJ; Park K; Lee CM; Kim J
    Gynecol Oncol; 2005 May; 97(2):337-41. PubMed ID: 15863127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of cyclooxygenase-2 protein and its relationship to apoptosis in cervical carcinoma treated with neoadjuvant chemotherapy.
    Nagai N; Tian X; Mukai K; Hirata E; Kusuda T; Shiroyama Y; Shigemasa K; Ohama K
    Int J Mol Med; 2003 Nov; 12(5):709-14. PubMed ID: 14532998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 expression in endometrial carcinoma: correlation with clinicopathologic parameters and clinical outcome.
    Ferrandina G; Legge F; Ranelletti FO; Zannoni GF; Maggiano N; Evangelisti A; Mancuso S; Scambia G; Lauriola L
    Cancer; 2002 Aug; 95(4):801-7. PubMed ID: 12209724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoplasmic HuR expression correlates with poor outcome and with cyclooxygenase 2 expression in serous ovarian carcinoma.
    Erkinheimo TL; Lassus H; Sivula A; Sengupta S; Furneaux H; Hla T; Haglund C; Butzow R; Ristimäki A
    Cancer Res; 2003 Nov; 63(22):7591-4. PubMed ID: 14633672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in ovarian surface epithelial carcinomas: is there any correlation with angiogenesis or clinicopathologic parameters?
    Ozel E; Peştereli HE; Simşek T; Erdoğan G; Karaveli FS
    Int J Gynecol Cancer; 2006; 16(2):549-55. PubMed ID: 16681724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship of cyclooxygenase 2 expression and chemotherapy response and prognosis in human ovarian carcinoma].
    Lou WZ; Shen K; Zhang Y; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2004 Aug; 39(8):529-32. PubMed ID: 15363351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium.
    Orejuela FJ; Ramondetta LM; Smith J; Brown J; Lemos LB; Li Y; Hollier LM
    Gynecol Oncol; 2005 May; 97(2):483-8. PubMed ID: 15863148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cyclooxygenase-2 and its relationship to p53 accumulation in ovarian adenocarcinomas.
    Shigemasa K; Tian X; Gu L; Shiroyama Y; Nagai N; Ohama K
    Int J Oncol; 2003 Jan; 22(1):99-105. PubMed ID: 12469191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2: a possible target in schistosoma-associated bladder cancer.
    El-Sheikh SS; Madaan S; Alhasso A; Abel P; Stamp G; Lalani EN
    BJU Int; 2001 Dec; 88(9):921-7. PubMed ID: 11851614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.